Skip to main content
OpenTrials

Clinical trial condition

Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST)

Explore clinical trials studying Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST) trial results

Completed

A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

NCT00237185

Conditions
Albinism, Amino Acid Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +21 more
Locations
  • Dana Farber Cancer Institute Dept of Sarcoma Oncology Boston, Massachusetts, United States
  • Oregon Health Sciences University Dept. of Oregon Health Sci. Portland, Oregon, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • Novartis Investigative Site Geelong, Victoria, Australia
View Trial Details

Related conditions